Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma
Clinical trial NCT05317819 · RECRUITING
Trial details
- NCT number
- NCT05317819
- Sponsor
- Polaris Group
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-14
- Primary completion
- 2028-09-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.